The study aimes to evaluate the neoplasm proteomic changes in benign follicular adenoma versus malignant follicular variant of papillary thyroid carcinoma. Tumor and non-tumor adjacent samples were an

NIAID Data Ecosystem50

Cell fate decision by a morphogen-transcription factor-chromatin modifier axis

细胞命运决定

发育信号与表观调控

Cell fate decision by a morphogen-transcription factor-chromatin modifier axis

integrated proteome resources40

Additional file 5 of Integrated analysis of circulating and tissue proteomes reveals that fibronectin 1 is a potential biomarker in papillary thyroid cancer

甲状腺蛋白质组学

肿瘤生物标志物

Additional file 5: Supplementary Table S5. Differentially expressed proteins between tumor tissues and paired non-cancerous adjacent tissues of papillary thyroid cancer patients.

Figshare2024-02-14 更新60

Additional file 4 of Integrated analysis of circulating and tissue proteomes reveals that fibronectin 1 is a potential biomarker in papillary thyroid cancer

甲状腺蛋白质组学

癌症生物标志物

Additional file 4: Supplementary Table S4. All Proteins identified in tumor tissues and paired non-cancerous adjacent tissues of papillary thyroid cancer patients by DIA-MS.

Figshare2024-02-14 更新50

Proteotypic differences of follicular-patterned thyroid neoplasms

资源简介：

相关数据集